Dementia: A common vaccine may not just lower the risk, it could also help treat it
A large-scale study suggests the shingles vaccine may significantly lower dementia risk by approximately 20% and potentially slow its progression in diagnosed individuals. This observational research, particularly pronounced in women, points to a promising, cost-effective intervention for dementia prevention and treatment. Formal trials are now needed to confirm these findings.
A large-scale study suggests the shingles vaccine may significantly lower dementia risk by approximately 20% and potentially slow its progression in diagnosed individuals. This observational research, particularly pronounced in women, points to a promising, cost-effective intervention for dementia prevention and treatment. Formal trials are now needed to confirm these findings.
